| 000 | 01090 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517201647.0 | ||
| 264 | 0 | _c20190802 | |
| 008 | 201908s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-18-0183 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKorn, Edward L | |
| 245 | 0 | 0 |
_aSurrogate and Intermediate Endpoints in Randomized Trials: What's the Goal? _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _c05 2018 |
||
| 300 |
_a2239-2240 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 | _aBiomarkers |
| 650 | 0 | 4 | _aGoals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunologic Factors |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 | _aProgression-Free Survival |
| 700 | 1 | _aFreidlin, Boris | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 24 _gno. 10 _gp. 2239-2240 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-18-0183 _zAvailable from publisher's website |
| 999 |
_c28082639 _d28082639 |
||